UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:CLTC-TFE3 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: CLTC-TFE3 | FusionPDB ID: 17412 | FusionGDB2.0 ID: 17412 | Hgene | Tgene | Gene symbol | CLTC | TFE3 | Gene ID | 1213 | 7030 |
Gene name | clathrin heavy chain | transcription factor binding to IGHM enhancer 3 | |
Synonyms | CHC|CHC17|CLH-17|CLTCL2|Hc|MRD56 | RCCP2|RCCX1|TFEA|bHLHe33 | |
Cytomap | 17q23.1 | Xp11.23 | |
Type of gene | protein-coding | protein-coding | |
Description | clathrin heavy chain 1clathrin heavy chain on chromosome 17clathrin, heavy polypeptide (Hc)clathrin, heavy polypeptide-like 2 | transcription factor E3class E basic helix-loop-helix protein 33transcription factor E family, member Atranscription factor for IgH enhancertranscription factor for immunoglobulin heavy-chain enhancer 3 | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | P53675 | P19532 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000269122, ENST00000393043, ENST00000579456, ENST00000579815, | ENST00000487451, ENST00000315869, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 27 X 40 X 17=18360 | 14 X 15 X 6=1260 |
# samples | 84 | 15 | |
** MAII score | log2(84/18360*10)=-4.45003292063505 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/1260*10)=-3.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: CLTC [Title/Abstract] AND TFE3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | |||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CLTC | GO:1900126 | negative regulation of hyaluronan biosynthetic process | 24251095 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerKB3 | . | . | CLTC | chr17 | 57754549 | + | TFE3 | chrX | 48891766 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000393043 | CLTC | chr17 | 57754549 | + | ENST00000315869 | TFE3 | chrX | 48891766 | - | 5340 | 3070 | 274 | 3912 | 1212 |
ENST00000269122 | CLTC | chr17 | 57754549 | + | ENST00000315869 | TFE3 | chrX | 48891766 | - | 5340 | 3070 | 274 | 3912 | 1212 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >17412_17412_1_CLTC-TFE3_CLTC_chr17_57754549_ENST00000269122_TFE3_chrX_48891766_ENST00000315869_length(amino acids)=1212AA_BP=932 MAQILPIRFQEHLQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASKVIALKAGKTLQI FNIEMKSKMKAHTMTDDVTFWKWISLNTVALVTDNAVYHWSMEGESQPVKMFDRHSSLAGCQIINYRTDAKQKWLLLTGISAQQNRVVGA MQLYSVDRKVSQPIEGHAASFAQFKMEGNAEESTLFCFAVRGQAGGKLHIIEVGTPPTGNQPFPKKAVDVFFPPEAQNDFPVAMQISEKH DVVFLITKYGYIHLYDLETGTCIYMNRISGETIFVTAPHEATAGIIGVNRKGQVLSVCVEEENIIPYITNVLQNPDLALRMAVRNNLAGA EELFARKFNALFAQGNYSEAAKVAANAPKGILRTPDTIRRFQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELCRPVLQQGRKQLLEK WLKEDKLECSEELGDLVKSVDPTLALSVYLRANVPNKVIQCFAETGQVQKIVLYAKKVGYTPDWIFLLRNVMRISPDQGQQFAQMLVQDE EPLADITQIVDVFMEYNLIQQCTAFLLDALKNNRPSEGPLQTRLLEMNLMHAPQVADAILGNQMFTHYDRAHIAQLCEKAGLLQRALEHF TDLYDIKRAVVHTHLLNPEWLVNYFGSLSVEDSLECLRAMLSANIRQNLQICVQVASKYHEQLSTQSLIELFESFKSFEGLFYFLGSIVN FSQDPDVHFKYIQAACKTGQIKEVERICRESNCYDPERVKNFLKEAKLTDQLPLIIVCDRFDFVHDLVLYLYRNNLQKYIEIYVQKVNPS RLPVVIGGLLDVDCSEDVIKNLILVVRGQFSTDELVAEVEKRNRLKLLLPWLEARIHEGCEEPATHNALAKIYIDSNNNPERFLRENPYY DSRVVGKYCEKRDPHLACVAYERGQCDLELINLPVSGNLLDVYSSQGVATPAITVSNSCPAELPNIKREISETEAKALLKERQKKDNHNL IERRRRFNINDRIKELGTLIPKSSDPEMRWNKGTILKASVDYIRKLQKEQQRSKDLESRQRSLEQANRSLQLRIQELELQAQIHGLPVPP TPGLLSLATTSASDSLKPEQLDIEEEGRPGAATFHVGGGPAQNAPHQQPPAPPSDALLDLHFPSDHLGDLGDPFHLGLEDILMEEEEGVV -------------------------------------------------------------- >17412_17412_2_CLTC-TFE3_CLTC_chr17_57754549_ENST00000393043_TFE3_chrX_48891766_ENST00000315869_length(amino acids)=1212AA_BP=932 MAQILPIRFQEHLQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASKVIALKAGKTLQI FNIEMKSKMKAHTMTDDVTFWKWISLNTVALVTDNAVYHWSMEGESQPVKMFDRHSSLAGCQIINYRTDAKQKWLLLTGISAQQNRVVGA MQLYSVDRKVSQPIEGHAASFAQFKMEGNAEESTLFCFAVRGQAGGKLHIIEVGTPPTGNQPFPKKAVDVFFPPEAQNDFPVAMQISEKH DVVFLITKYGYIHLYDLETGTCIYMNRISGETIFVTAPHEATAGIIGVNRKGQVLSVCVEEENIIPYITNVLQNPDLALRMAVRNNLAGA EELFARKFNALFAQGNYSEAAKVAANAPKGILRTPDTIRRFQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELCRPVLQQGRKQLLEK WLKEDKLECSEELGDLVKSVDPTLALSVYLRANVPNKVIQCFAETGQVQKIVLYAKKVGYTPDWIFLLRNVMRISPDQGQQFAQMLVQDE EPLADITQIVDVFMEYNLIQQCTAFLLDALKNNRPSEGPLQTRLLEMNLMHAPQVADAILGNQMFTHYDRAHIAQLCEKAGLLQRALEHF TDLYDIKRAVVHTHLLNPEWLVNYFGSLSVEDSLECLRAMLSANIRQNLQICVQVASKYHEQLSTQSLIELFESFKSFEGLFYFLGSIVN FSQDPDVHFKYIQAACKTGQIKEVERICRESNCYDPERVKNFLKEAKLTDQLPLIIVCDRFDFVHDLVLYLYRNNLQKYIEIYVQKVNPS RLPVVIGGLLDVDCSEDVIKNLILVVRGQFSTDELVAEVEKRNRLKLLLPWLEARIHEGCEEPATHNALAKIYIDSNNNPERFLRENPYY DSRVVGKYCEKRDPHLACVAYERGQCDLELINLPVSGNLLDVYSSQGVATPAITVSNSCPAELPNIKREISETEAKALLKERQKKDNHNL IERRRRFNINDRIKELGTLIPKSSDPEMRWNKGTILKASVDYIRKLQKEQQRSKDLESRQRSLEQANRSLQLRIQELELQAQIHGLPVPP TPGLLSLATTSASDSLKPEQLDIEEEGRPGAATFHVGGGPAQNAPHQQPPAPPSDALLDLHFPSDHLGDLGDPFHLGLEDILMEEEEGVV -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:/chrX:) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CLTC | TFE3 |
FUNCTION: Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Two different adapter protein complexes link the clathrin lattice either to the plasma membrane or to the trans-Golgi network (By similarity). {ECO:0000250}. | FUNCTION: Transcription factor that acts as a master regulator of lysosomal biogenesis and immune response (PubMed:2338243, PubMed:29146937, PubMed:30733432, PubMed:31672913). Specifically recognizes and binds E-box sequences (5'-CANNTG-3'); efficient DNA-binding requires dimerization with itself or with another MiT/TFE family member such as TFEB or MITF (By similarity). Involved in the cellular response to amino acid availability by acting downstream of MTOR: in the presence of nutrients, TFE3 phosphorylation by MTOR promotes its cytosolic retention and subsequent inactivation (PubMed:31672913). Upon starvation or lysosomal stress, inhibition of MTOR induces TFE3 dephosphorylation, resulting in nuclear localization and transcription factor activity (PubMed:31672913). In association with TFEB, activates the expression of CD40L in T-cells, thereby playing a role in T-cell-dependent antibody responses in activated CD4(+) T-cells and thymus-dependent humoral immunity (By similarity). Specifically recognizes the MUE3 box, a subset of E-boxes, present in the immunoglobulin enhancer (PubMed:2338243). It also binds very well to a USF/MLTF site (PubMed:2338243). May regulate lysosomal positioning in response to nutrient deprivation by promoting the expression of PIP4P1 (PubMed:29146937). Acts as a positive regulator of browning of adipose tissue by promoting expression of target genes; mTOR-dependent phosphorylation promotes cytoplasmic retention of TFE3 and inhibits browning of adipose tissue (By similarity). Maintains the pluripotent state of embryonic stem cells by promoting the expression of genes such as ESRRB; mTOR-dependent nuclear exclusion promotes exit from pluripotency (By similarity). Required to maintain the naive pluripotent state of hematopoietic stem cell; mTOR-dependent cytoplasmic retention of TFE3 promotes the exit of hematopoietic stem cell from pluripotency (PubMed:30733432). {ECO:0000250|UniProtKB:Q64092, ECO:0000269|PubMed:2338243, ECO:0000269|PubMed:29146937, ECO:0000269|PubMed:30733432, ECO:0000269|PubMed:31672913}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file (859) >>>859.pdbFusion protein BP residue: 932 CIF file (859) >>>859.cif | CLTC | chr17 | 57754549 | + | TFE3 | chrX | 48891766 | - | MAQILPIRFQEHLQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQV VIIDMNDPSNPIRRPISADSAIMNPASKVIALKAGKTLQIFNIEMKSKMK AHTMTDDVTFWKWISLNTVALVTDNAVYHWSMEGESQPVKMFDRHSSLAG CQIINYRTDAKQKWLLLTGISAQQNRVVGAMQLYSVDRKVSQPIEGHAAS FAQFKMEGNAEESTLFCFAVRGQAGGKLHIIEVGTPPTGNQPFPKKAVDV FFPPEAQNDFPVAMQISEKHDVVFLITKYGYIHLYDLETGTCIYMNRISG ETIFVTAPHEATAGIIGVNRKGQVLSVCVEEENIIPYITNVLQNPDLALR MAVRNNLAGAEELFARKFNALFAQGNYSEAAKVAANAPKGILRTPDTIRR FQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELCRPVLQQGRKQLLEK WLKEDKLECSEELGDLVKSVDPTLALSVYLRANVPNKVIQCFAETGQVQK IVLYAKKVGYTPDWIFLLRNVMRISPDQGQQFAQMLVQDEEPLADITQIV DVFMEYNLIQQCTAFLLDALKNNRPSEGPLQTRLLEMNLMHAPQVADAIL GNQMFTHYDRAHIAQLCEKAGLLQRALEHFTDLYDIKRAVVHTHLLNPEW LVNYFGSLSVEDSLECLRAMLSANIRQNLQICVQVASKYHEQLSTQSLIE LFESFKSFEGLFYFLGSIVNFSQDPDVHFKYIQAACKTGQIKEVERICRE SNCYDPERVKNFLKEAKLTDQLPLIIVCDRFDFVHDLVLYLYRNNLQKYI EIYVQKVNPSRLPVVIGGLLDVDCSEDVIKNLILVVRGQFSTDELVAEVE KRNRLKLLLPWLEARIHEGCEEPATHNALAKIYIDSNNNPERFLRENPYY DSRVVGKYCEKRDPHLACVAYERGQCDLELINLPVSGNLLDVYSSQGVAT PAITVSNSCPAELPNIKREISETEAKALLKERQKKDNHNLIERRRRFNIN DRIKELGTLIPKSSDPEMRWNKGTILKASVDYIRKLQKEQQRSKDLESRQ RSLEQANRSLQLRIQELELQAQIHGLPVPPTPGLLSLATTSASDSLKPEQ LDIEEEGRPGAATFHVGGGPAQNAPHQQPPAPPSDALLDLHFPSDHLGDL GDPFHLGLEDILMEEEEGVVGGLSGGALSPLRAASDPLLSSVSPAVSKAS | 1212 |
3D view using mol* of 859 (AA BP:932) | ||||||||||
![]() |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
CLTC_pLDDT.png![]() |
TFE3_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
CLTC_TFE3_859_pLDDT.png (AA BP:932)![]() |
CLTC_TFE3_859_pLDDT_and_active_sites.png (AA BP:932)![]() |
CLTC_TFE3_859_violinplot.png (AA BP:932)![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
CLTC_TFE3_859.png |
![]() |
Top |
Potential Active Site Information |
![]() |
Fusion AA seq ID in FusionPDB | Site score | Size | D score | Volume | Exposure | Enclosure | Contact | Phobic | Philic | Balance | Don/Acc | Residues |
859 | 1.044 | 359 | 1.062 | 932.274 | 0.529 | 0.756 | 0.955 | 0.536 | 1.017 | 0.527 | 0.704 | Chain A: 26,27,28,29,30,31,32,33,34,41,69,70,71,72 ,75,76,83,108,109,110,111,112,113,114,115,116,124, 144,151,152,153,154,155,156,157,158,159,160,162,16 6,168,170,197,198,199,200,201,202,203,214,260,262, 263,264,265,266,267,268,269,278,302,304,305,306,30 7,308,310,313,320 |
Top |
Potentially Interacting Small Molecules through Virtual Screening |
![]() |
Fusion AA seq ID in FusionPDB | ZINC ID | DrugBank ID | Drug name | Docking score | Glide gscore |
859 | ZINC000014210876 | DB09272 | Eluxadoline | -5.40873 | -6.13633 |
859 | ZINC000000057624 | DB00368 | Norepinephrine | -6.09449 | -6.11199 |
859 | ZINC000008214483 | DB00479 | Amikacin | -5.95929 | -6.03649 |
859 | ZINC000000895457 | DB08847 | Hydroxyproline | -6.01408 | -6.01408 |
859 | ZINC000029416466 | DB01232 | Saquinavir | -5.98867 | -6.00187 |
859 | ZINC000000034157 | DB06707 | Levonordefrin | -5.97621 | -5.99371 |
859 | ZINC000000388081 | DB05381 | Histamine | -4.5534 | -5.885 |
859 | ZINC000000895302 | DB06770 | Benzyl alcohol | -5.88406 | -5.88406 |
859 | ZINC000029571072 | DB06636 | Isavuconazonium | -5.424 | -5.856 |
859 | ZINC000000020259 | DB00852 | Pseudoephedrine | -5.82006 | -5.82676 |
859 | ZINC000019166991 | DB00780 | Phenelzine | -4.96968 | -5.75018 |
859 | ZINC000000000746 | DB00871 | Terbutaline | -5.72374 | -5.73804 |
859 | ZINC000003794794 | DB01204 | Mitoxantrone | -5.71531 | -5.71531 |
859 | ZINC000000896731 | DB00744 | Zileuton | -5.67916 | -5.69776 |
859 | ZINC000000000469 | DB00816 | Orciprenaline | -5.65382 | -5.66822 |
859 | ZINC000000004893 | DB06216 | Asenapine | -5.64894 | -5.65294 |
859 | ZINC000000113355 | DB00388 | Phenylephrine | -5.64489 | -5.65159 |
859 | ZINC000100007011 | DB00302 | Tranexamic acid | -5.62982 | -5.62982 |
859 | ZINC000000643055 | DB01127 | Econazole | -4.89885 | -5.62185 |
859 | ZINC000019168887 | DB00190 | Carbidopa | -5.55606 | -5.55606 |
Top |
![]() |
ZINC ID | DrugBank ID | Drug name | Drug type | SMILES | Drug group |
ZINC000014210876 | DB09272 | Eluxadoline | Small molecule | COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O | Approved|Investigational |
ZINC000000057624 | DB00368 | Norepinephrine | Small molecule | NC[C@H](O)C1=CC(O)=C(O)C=C1 | Approved |
ZINC000008214483 | DB00479 | Amikacin | Small molecule | NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O | Approved|Investigational|Vet_approved |
ZINC000000895457 | DB08847 | Hydroxyproline | Small molecule | O[C@H]1CN[C@@H](C1)C(O)=O | Experimental |
ZINC000000034157 | DB06707 | Levonordefrin | Small molecule | C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1 | Approved |
ZINC000000388081 | DB05381 | Histamine | Small molecule | NCCC1=CNC=N1 | Approved|Investigational |
ZINC000000895302 | DB06770 | Benzyl alcohol | Small molecule | OCC1=CC=CC=C1 | Approved |
ZINC000000020259 | DB00852 | Pseudoephedrine | Small molecule | CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 | Approved |
ZINC000019166991 | DB00780 | Phenelzine | Small molecule | NNCCC1=CC=CC=C1 | Approved |
ZINC000003794794 | DB01204 | Mitoxantrone | Small molecule | OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C(O)=CC=C1O)C2=O | Approved|Investigational |
ZINC000000896731 | DB00744 | Zileuton | Small molecule | CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1 | Approved|Investigational|Withdrawn |
ZINC000000000469 | DB00816 | Orciprenaline | Small molecule | CC(C)NCC(O)C1=CC(O)=CC(O)=C1 | Approved |
ZINC000000113355 | DB00388 | Phenylephrine | Small molecule | CNC[C@H](O)C1=CC(O)=CC=C1 | Approved |
ZINC000000643055 | DB01127 | Econazole | Small molecule | ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1 | Approved |
ZINC000019168887 | DB00190 | Carbidopa | Small molecule | C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O | Approved |
Top |
Biochemical Features of Small Molecules |
![]() |
ZINC ID | mol_MW | dipole | SASA | FOSA | FISA | PISA | WPSA | volume | donorHB | accptHB | IP | Human Oral Absorption | Percent Human Oral Absorption | Rule Of Five | Rule Of Three |
ZINC000014210876 | 569.659 | 7.127 | 866.349 | 287.048 | 259.904 | 319.397 | 0 | 1681.617 | 6 | 10.75 | 8.689 | 1 | 7.538 | 2 | 2 |
ZINC000014210876 | 569.659 | 3.679 | 901.19 | 287.315 | 271.102 | 342.773 | 0 | 1718.172 | 6 | 10.75 | 8.888 | 1 | 6.546 | 2 | 2 |
ZINC000014210876 | 569.659 | 6.683 | 902.919 | 270.324 | 282.937 | 349.658 | 0 | 1740.575 | 6 | 10.75 | 8.92 | 1 | 4.831 | 2 | 2 |
ZINC000014210876 | 569.659 | 6.148 | 862.573 | 279.279 | 281.556 | 301.737 | 0 | 1689.73 | 6 | 10.75 | 8.984 | 1 | 3.053 | 2 | 2 |
ZINC000014210876 | 569.659 | 14.843 | 858.111 | 275.061 | 269.062 | 313.988 | 0 | 1679.1 | 6 | 10.75 | 9.133 | 1 | 6.013 | 2 | 2 |
ZINC000014210876 | 569.659 | 14.363 | 896.983 | 280.954 | 265.963 | 350.066 | 0 | 1717.668 | 6 | 10.75 | 9.01 | 1 | 7.352 | 2 | 2 |
ZINC000000057624 | 169.18 | 3.43 | 375.225 | 57.715 | 204.72 | 112.79 | 0 | 592.168 | 5 | 4.2 | 8.952 | 2 | 46.791 | 0 | 0 |
ZINC000000057624 | 169.18 | 2.409 | 366.478 | 58.999 | 201.357 | 106.122 | 0 | 584.369 | 5 | 4.2 | 8.77 | 2 | 47.306 | 0 | 0 |
ZINC000008214483 | 585.607 | 7.114 | 830.321 | 338.822 | 491.499 | 0 | 0 | 1599.846 | 17 | 26.9 | 9.629 | 1 | 0 | 3 | 2 |
ZINC000008214483 | 585.607 | 4.555 | 814.872 | 354.051 | 460.821 | 0 | 0 | 1597.338 | 17 | 26.9 | 9.424 | 1 | 0 | 3 | 2 |
ZINC000008214483 | 585.607 | 12.3 | 828.375 | 361.409 | 466.966 | 0 | 0 | 1597.745 | 17 | 26.9 | 9.497 | 1 | 0 | 3 | 2 |
ZINC000000895457 | 131.131 | 7.237 | 313.333 | 137.57 | 175.763 | 0 | 0 | 472.628 | 3 | 5.2 | 10.259 | 2 | 30.299 | 0 | 1 |
ZINC000029416466 | 670.85 | 6.154 | 1020.69 | 508.33 | 132.906 | 379.454 | 0 | 2024.819 | 5 | 13.7 | 8.648 | 2 | 39.157 | 3 | 1 |
ZINC000029416466 | 670.85 | 5.818 | 1108.855 | 506.927 | 192.124 | 409.803 | 0 | 2112.978 | 5 | 13.7 | 8.927 | 2 | 26.101 | 3 | 2 |
ZINC000029416466 | 670.85 | 4.107 | 1071.641 | 527.824 | 184.088 | 359.729 | 0 | 2091.307 | 5 | 13.7 | 8.879 | 2 | 26.788 | 3 | 2 |
ZINC000000034157 | 183.207 | 1.584 | 399.847 | 106.772 | 186.848 | 106.227 | 0 | 646.199 | 5 | 4.2 | 8.948 | 2 | 52.109 | 0 | 0 |
ZINC000000034157 | 183.207 | 2.284 | 398.836 | 105.841 | 186.106 | 106.889 | 0 | 643.154 | 5 | 4.2 | 8.781 | 2 | 52.19 | 0 | 0 |
ZINC000000388081 | 111.146 | 4.788 | 315.231 | 92.229 | 118.535 | 104.468 | 0 | 466.776 | 3 | 2.5 | 9.295 | 2 | 65.253 | 0 | 0 |
ZINC000000388081 | 111.146 | 5.535 | 313.532 | 90.818 | 116.688 | 106.026 | 0 | 465.559 | 3 | 3 | 9.188 | 2 | 64.917 | 0 | 0 |
ZINC000000388081 | 111.146 | 4.794 | 316.569 | 91.628 | 116.549 | 108.393 | 0 | 470.468 | 3 | 2.5 | 9.292 | 2 | 65.823 | 0 | 0 |
ZINC000000895302 | 108.14 | 2.044 | 309.517 | 49.935 | 55.235 | 204.347 | 0 | 461.187 | 1 | 1.7 | 9.646 | 3 | 95.537 | 0 | 0 |
ZINC000000020259 | 165.235 | 1.645 | 408.608 | 167.774 | 58.787 | 182.046 | 0 | 662.697 | 2 | 3.2 | 9.158 | 3 | 84.991 | 0 | 0 |
ZINC000000020259 | 165.235 | 1.679 | 405.001 | 165.637 | 58.444 | 180.921 | 0 | 657.176 | 2 | 3.2 | 9.01 | 3 | 84.846 | 0 | 0 |
ZINC000019166991 | 136.196 | 3.232 | 356.423 | 81.765 | 87.193 | 187.466 | 0 | 561.686 | 3 | 1.5 | 8.991 | 2 | 63.334 | 0 | 0 |
ZINC000019166991 | 136.196 | 3.226 | 364.816 | 72.471 | 95.426 | 196.919 | 0 | 568.553 | 3 | 1.5 | 9.191 | 2 | 61.887 | 0 | 0 |
ZINC000019166991 | 136.196 | 1.465 | 367.921 | 74.226 | 96.877 | 196.818 | 0 | 568.82 | 3 | 1.5 | 9.505 | 2 | 61.575 | 0 | 0 |
ZINC000000000746 | 225.287 | 3.599 | 496.174 | 234.367 | 155.26 | 106.547 | 0 | 827.344 | 4 | 4.2 | 9.067 | 2 | 61.87 | 0 | 0 |
ZINC000000000746 | 225.287 | 1.595 | 496.002 | 233.982 | 154.54 | 107.48 | 0 | 824.986 | 4 | 4.2 | 8.979 | 2 | 61.981 | 0 | 0 |
ZINC000003794794 | 444.486 | 5.02 | 786.306 | 339.526 | 291.766 | 155.014 | 0 | 1393.63 | 4 | 9.9 | 7.456 | 1 | 17.859 | 1 | 2 |
ZINC000000896731 | 236.288 | 3.773 | 444.598 | 84.301 | 131.134 | 195.105 | 34.058 | 746.481 | 3 | 3.7 | 8.644 | 3 | 78.18 | 0 | 0 |
ZINC000000896731 | 236.288 | 5.297 | 450.816 | 85.528 | 135.414 | 201.881 | 27.993 | 746.812 | 3 | 3.7 | 8.57 | 3 | 76.556 | 0 | 0 |
ZINC000000000469 | 211.26 | 2.192 | 479.658 | 212.457 | 159.848 | 107.353 | 0 | 782.094 | 4 | 4.7 | 9.205 | 2 | 61.391 | 0 | 0 |
ZINC000000000469 | 211.26 | 3.668 | 477.852 | 212.113 | 158.053 | 107.685 | 0 | 779.059 | 4 | 4.7 | 8.929 | 2 | 61.69 | 0 | 0 |
ZINC000000004893 | 285.772 | 2.935 | 505.956 | 170.474 | 8.432 | 255.473 | 71.578 | 892.611 | 0 | 2.5 | 9.23 | 3 | 100 | 0 | 0 |
ZINC000000004893 | 285.772 | 2.515 | 507.857 | 169.705 | 8.429 | 258.17 | 71.553 | 893.39 | 0 | 2.5 | 9.299 | 3 | 100 | 0 | 0 |
ZINC000000113355 | 167.207 | 2.072 | 404.418 | 139.15 | 116.415 | 148.853 | 0 | 642.532 | 3 | 3.95 | 9.18 | 2 | 68.881 | 0 | 0 |
ZINC000000113355 | 167.207 | 2.123 | 400.929 | 135.071 | 117.85 | 148.008 | 0 | 637.052 | 3 | 3.95 | 9.132 | 2 | 68.369 | 0 | 0 |
ZINC000100007011 | 157.212 | 1.799 | 375.783 | 216.456 | 159.327 | 0 | 0 | 603.499 | 3 | 3 | 9.574 | 2 | 42.471 | 0 | 1 |
ZINC000000643055 | 381.688 | 3.522 | 625.94 | 65.524 | 30.702 | 344.327 | 185.387 | 1104.84 | 0 | 3.7 | 9.333 | 3 | 100 | 1 | 1 |
ZINC000000643055 | 381.688 | 5.315 | 630.727 | 59.729 | 32.959 | 342.705 | 195.334 | 1112.719 | 0 | 3.7 | 9.213 | 3 | 100 | 1 | 1 |
ZINC000019168887 | 226.232 | 3.09 | 431.117 | 96.823 | 239.533 | 94.761 | 0 | 720.488 | 5 | 4 | 8.924 | 1 | 0 | 1 | 1 |
Top |
Drug Toxicity Information |
![]() |
ZINC ID | Smile | Surface Accessibility | Toxicity |
ZINC000014210876 | COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O | 0.067819743 | 0.140534867 |
ZINC000000057624 | NC[C@H](O)c1ccc(O)c(O)c1 | 0.18714743 | 0.309816979 |
ZINC000008214483 | NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O | 0.013735555 | 0.304219313 |
ZINC000000895457 | O=C(O)[C@H]1C[C@H](O)CN1 | 0.099278267 | 0.470163896 |
ZINC000029416466 | CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1 | 0.039248776 | 0.333476835 |
ZINC000000034157 | C[C@H](N)[C@H](O)c1ccc(O)c(O)c1 | 0.135079192 | 0.302260037 |
ZINC000000388081 | NCCc1cnc[nH]1 | 0.212944784 | 0.352067312 |
ZINC000000895302 | OCc1ccccc1 | 0.868750215 | 0.569537247 |
ZINC000029571072 | CNCC(=O)OCc1cccnc1N(C)C(=O)O[C@H](C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1 | 0.025416027 | 0.235213823 |
ZINC000000020259 | CN[C@@H](C)[C@@H](O)c1ccccc1 | 0.208587895 | 0.312560893 |
ZINC000019166991 | NNCCc1ccccc1 | 0.488722672 | 0.493119705 |
ZINC000000000746 | CC(C)(C)NC[C@H](O)c1cc(O)cc(O)c1 | 0.159845213 | 0.248277396 |
ZINC000003794794 | O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 | 0.162924055 | 0.487926509 |
ZINC000000896731 | C[C@H](c1cc2ccccc2s1)N(O)C(N)=O | 0.136335882 | 0.223511692 |
ZINC000000000469 | CC(C)NC[C@@H](O)c1cc(O)cc(O)c1 | 0.170221255 | 0.19797014 |
ZINC000000004893 | CN1C[C@H]2c3ccccc3Oc3ccc(Cl)cc3[C@@H]2C1 | 0.133117695 | 0.325998169 |
ZINC000000113355 | CNC[C@H](O)c1cccc(O)c1 | 0.227655864 | 0.251523685 |
ZINC000100007011 | NC[C@@H]1CC[C@@H](C(=O)O)CC1 | 0.34357774 | 0.472488357 |
ZINC000000643055 | Clc1ccc(CO[C@@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 | 0.179820754 | 0.346527688 |
ZINC000019168887 | C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O | 0.136835962 | 0.241973462 |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
CLTC | HGS, MCC, IKBKE, TFE3, SNX5, TOM1, SNX9, DNAJC6, ARMCX3, C10orf88, EPN1, EHD1, GGA1, GGA2, GGA3, KIT, AMPH, CLINT1, TNK2, LDLRAP1, HIP1, AP1B1, AP2A2, AP3B2, MAP3K10, PICALM, EPN2, Epn1, VCL, Arrb2, STAMBP, STAMBPL1, STAM, MAP1LC3A, SNCA, PRKACA, WNK1, Mapk13, HDAC5, SPG20, RICTOR, Erh, Cd2ap, Pttg1, EBNA-LP, PCM1, NDRG1, PPP1CA, ITSN1, ARRB1, SIRT7, SH3KBP1, DYRK1A, SNAP91, AP2B1, BIN1, AP1G1, RAC1, TOM1L1, TOM1L2, ISG15, CUL3, CUL5, CUL2, CDK2, CUL1, COPS5, DCUN1D1, CAND1, NEDD8, XRCC6, HERC1, ATG16L1, SYNJ1, LRRK2, Nfe2l2, AKT1, GRB2, SHC1, AP2M1, MYO6, SRC, FYN, Htt, DNAJA3, RPSA, ESR1, PAXIP1, PPP1CC, SMURF1, ARRB2, ERBB2, FN1, VCAM1, Fcho2, DAB2, UBL4A, ITGA4, MYBL2, SVIL, PAN2, NPM1, PTAFR, ATP4A, EP300, QARS, YWHAQ, FBXO6, RPA1, RPA2, RPA3, ERG, EPHA2, LGR4, Fbxl16, STAU1, TP53, HUWE1, FBXW11, GJB5, NXF1, ADRB2, AVPR2, CUL7, OBSL1, CCDC8, EED, ZFYVE9, OCRL, ATR, SCYL2, HTR6, HNRNPA1, UNK, ATP1A1, ATP1A2, ATP1A3, ATP5C1, CCDC47, CCT3, CCT6A, BLOC1S1, CAD, CANX, CCT6B, CISD1, CLTA, CYC1, DHX38, EHD2, FASTKD2, HSP90B1, IPO5, MTCH2, NDUFB9, NDUFS1, NLRP1, RAB5B, RANBP2, RANBP6, SLC25A3, SSR3, TECR, TOMM22, UQCRC2, VDAC1, VDAC2, VDAC3, ZMPSTE24, DDOST, EIF6, COX2, PHB, PHB2, PPP2R1A, PPP2R1B, RPN1, TMCO1, TUFM, UQCRQ, NTRK1, OFD1, CEP97, CNTRL, FBF1, NPHP1, DCTN1, POC5, POC1B, PPME1, ABCA2, PARP4, AP2A1, ATP6V1B2, ATP6V0A1, CAV1, CLTB, CAPZA2, DBN1, FLNA, GAK, MYH9, DNAJC7, IQGAP1, PDLIM7, SEC16A, SYNPO, MAPRE1, LIMA1, GTSE1, ANLN, MYO19, ARX, MYO18A, CSNK1A1, CSNK1E, STOM, EPS15, HSPA1A, HSPA4, NDUFA9, CHMP1A, PIK3C2A, PRKAR2A, SEC13, SOAT1, CLTCL1, SORBS2, PKP4, USO1, NUMB, TNK1, RAB11A, HIP1R, ATP6V0D1, XPR1, SEC24C, KIAA0430, IST1, HELZ, MVP, TROAP, SEC24B, RBM14, SEC23A, VTI1B, TRAFD1, PKP3, AAK1, BTBD3, TNRC6B, EDC4, DSTYK, PTPN23, NECAP1, TNRC6A, EHD4, EGFL7, ATP6V1D, PTRH2, PLEKHA5, CPVL, BMP2K, DCP1A, ERBB2IP, CHMP1B, KIDINS220, MTUS1, DENND1A, CRTC3, CPSF7, EDC3, CCDC115, FAM83A, REPS1, STON2, FCHO2, CHMP4B, MITD1, CRTC2, FAM83B, FAM83H, SLC35B2, Actb, Myh9, Myo1c, Ppp1cb, Tpm1, Coro1c, Cul3, Spast, Tmod3, Dctn3, Uso1, Lima1, Samm50, Calml3, Myh10, Strn3, Smap1, Ptpn23, Nhsl1, Sec24c, Flnb, IKBKB, MAP3K7, MCM2, AP3D1, U2AF2, CDC73, ZNF746, ARF6, CYLD, LASP1, BRCA1, TES, MTF1, BRD1, CFTR, ZNF598, PDGFRB, FBXO7, TMPO, PTCH1, HSPA8, MAP2K1, PIK3CA, APOE, BMPR1A, JUP, UQCRB, UBE2M, RAD18, PRPF8, EFTUD2, AAR2, PIH1D1, TNIP2, LARP7, RNF4, TNF, SPDL1, RIOK1, PRKCZ, HEXIM1, MEPCE, RUNX1, RNF123, PPT1, HERC2, UBE3A, AGR2, RECQL4, SMAP1, MYC, CDK9, Prkaa1, Prkab1, CDK5RAP2, GRWD1, KRT17, KIAA1429, PLEKHA2, RC3H2, ACTC1, TET2, NR2C2, UCHL3, PRDM16, MECOM, AGRN, BMH1, BMH2, ATXN3, TCF7L2, STX2, GSK3B, ABCC6, BIRC3, LMBR1L, WWP2, Hsp22, TRIM28, GJA1, TEX101, ARIH2, PLEKHA4, PINK1, YAP1, TFCP2, FANCD2, Clta, PXN, RALBP1, PTCHD3, C18orf54, ANKRD55, E, M, nsp13, nsp14, nsp4, nsp5, nsp6, ORF14, ORF3a, ORF6, ORF7a, ORF7b, ABCC2, CDCA5, ACO1, OPTN, NEK4, LRRC31, DUX4, CIT, AURKB, ECT2, KIF14, KIF20A, MAD2L2, KIF23, PRC1, PRNP, CHCHD1, HAX1, MFN2, SLC25A46, LDLR, SUMO2, PRKCB, Rnf183, AIMP2, BRD4, NINL, AFTPH, NUPR1, EPHA3, CIC, Apc2, RBM39, LGALS9, RIN3, EIF3H, DNAJA1, HSPA1L, HSPA2, HSPA6, BAG5, AR, UFL1, DDRGK1, CD3EAP, LAMTOR1, POLR2C, TRIM37, HTRA4, DRD2, ADRBK1, WDR5, PAGE4, NUDCD2, BGLT3, EDEM1, BAG2, DTX3, BTF3, IGF1R, NEDD4, FBXW7, TFRC, IFITM1, BSG, IFITM3, TMPRSS11B, CLEC4E, nsp15, ORF10, FGD5, MAP1LC3B, NBR1, CALCOCO2, SQSTM1, TOLLIP, Chrna4, SIRT6, PER2, |
TFE3 | AKR1B1, CLTC, PHB2, ACLY, CUL2, EPRS, PFAS, VARS, NEDD8, RPL38, TRIM28, EIF3A, RPA3, E2F3, SMARCE1, MITF, TFE3, SMAD3, SMAD4, TFEC, EWSR1, XPO1, TFEB, Arrb2, TARDBP, HIST1H4A, LAMTOR3, nsp2, nsp7, AIM2, NR3C1, DDX58, YWHAG, YWHAQ, HDAC5, BTF3, nsp16, IRF8, KLF12, KLF16, KLF3, KLF5, KLF8, SOX2, TLX3, VSX1, |
![]() |
Gene | STRING network |
CLTC | ![]() |
TFE3 | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to CLTC-TFE3 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to CLTC-TFE3 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CLTC | C4518356 | MiT family translocation renal cell carcinoma | 2 | ORPHANET |
Hgene | CLTC | C4693389 | MENTAL RETARDATION, AUTOSOMAL DOMINANT 56 | 2 | GENOMICS_ENGLAND;UNIPROT |
Hgene | CLTC | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
Hgene | CLTC | C0334121 | Inflammatory Myofibroblastic Tumor | 1 | ORPHANET |
Tgene | TFE3 | C4518356 | MiT family translocation renal cell carcinoma | 2 | ORPHANET |
Tgene | TFE3 | C0206657 | Alveolar Soft Part Sarcoma | 1 | ORPHANET |
Tgene | TFE3 | C0206732 | Epithelioid hemangioendothelioma | 1 | ORPHANET |